The Oklahoma House of Representatives has approved a bill to promote research into the therapeutic potential of psilocybin while providing legal protections against prosecution for people with eligible conditions who possess the psychedelic.
The legislation from Rep. Daniel Pae (R) cleared the chamber in a 66-32 vote on Thursday, about a month after the measure advanced through committee. It now heads to the Senate for consideration.
Prior to passing the bill, members adopted an amendment to strike the title, which is a typical legislative mechanism that removes the description at the top of the bill, technically putting it out of compliance with the state Constitution and requiring lawmakers to revisit it. It’s a way of advancing the legislation while recognizing that further changes are needed before a bill is enacted.
As revised in a House committee, the proposal calls for the establishment of a pilot program that would let universities as well as research facilities that contract with Oklahoma institutions of higher education carry out studies into psilocybin and psilocyn.
Research institutions would need to look into the use of the psychedelics for the treatment of post-traumatic stress disorder (PTSD), traumatic brain injury, early-stage dementia, palliative care, end-of-life care, opioid
Read full article on Marijuana Moment
